JP2023508011A5 - - Google Patents
Info
- Publication number
- JP2023508011A5 JP2023508011A5 JP2022537669A JP2022537669A JP2023508011A5 JP 2023508011 A5 JP2023508011 A5 JP 2023508011A5 JP 2022537669 A JP2022537669 A JP 2022537669A JP 2022537669 A JP2022537669 A JP 2022537669A JP 2023508011 A5 JP2023508011 A5 JP 2023508011A5
- Authority
- JP
- Japan
- Prior art keywords
- lemborexant
- child
- pharmaceutically acceptable
- acceptable salt
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025131238A JP2025160480A (ja) | 2019-12-20 | 2025-08-06 | 不眠症を治療するためのレンボレキサントの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962951638P | 2019-12-20 | 2019-12-20 | |
| US62/951,638 | 2019-12-20 | ||
| PCT/US2020/065891 WO2021127359A1 (en) | 2019-12-20 | 2020-12-18 | Use of lemborexant for treating insomnia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025131238A Division JP2025160480A (ja) | 2019-12-20 | 2025-08-06 | 不眠症を治療するためのレンボレキサントの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023508011A JP2023508011A (ja) | 2023-02-28 |
| JP2023508011A5 true JP2023508011A5 (https=) | 2023-12-22 |
Family
ID=74191874
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022537669A Pending JP2023508011A (ja) | 2019-12-20 | 2020-12-18 | 不眠症を治療するためのレンボレキサントの使用 |
| JP2025131238A Pending JP2025160480A (ja) | 2019-12-20 | 2025-08-06 | 不眠症を治療するためのレンボレキサントの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025131238A Pending JP2025160480A (ja) | 2019-12-20 | 2025-08-06 | 不眠症を治療するためのレンボレキサントの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230051268A1 (https=) |
| EP (1) | EP4076463A1 (https=) |
| JP (2) | JP2023508011A (https=) |
| KR (1) | KR20220119065A (https=) |
| CN (1) | CN115003305A (https=) |
| AU (1) | AU2020408557A1 (https=) |
| BR (1) | BR112022012246A2 (https=) |
| CA (1) | CA3165481A1 (https=) |
| MX (1) | MX2022007304A (https=) |
| TW (1) | TW202137986A (https=) |
| WO (1) | WO2021127359A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024305901A1 (en) * | 2023-06-29 | 2026-02-12 | Janssen Pharmaceutica Nv | Method of treating depression using seltorexant |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0828751A4 (en) | 1995-05-05 | 1999-01-20 | Human Genome Sciences Inc | HUMAN NEUROPEPTIDE RECEPTOR |
| US6309854B1 (en) | 1996-12-17 | 2001-10-30 | Smithkline Beecham Corporation | Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72 |
| US5935814A (en) | 1997-04-30 | 1999-08-10 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72Y receptor |
| US6020157A (en) | 1997-04-30 | 2000-02-01 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72X receptor |
| US6166193A (en) | 1997-07-25 | 2000-12-26 | Board Of Regents, University Of Texas System | Polynucleotides encoding MY1 receptor |
| AU2011304285B2 (en) | 2010-09-22 | 2015-01-29 | Eisai R&D Management Co., Ltd. | Cyclopropane compound |
| BR112014019909B1 (pt) | 2012-02-17 | 2020-01-28 | Eisai R&D Man Co Ltd | processo para produção de compostos úteis como antagonistas do receptor de orexina-2 |
| ES2843952T3 (es) | 2014-10-23 | 2021-07-21 | Eisai R&D Man Co Ltd | Composiciones para tratar el insomnio |
| CA3051830A1 (en) * | 2017-01-27 | 2018-08-02 | Neurocrine Bioscienes, Inc. | Methods for the administration of certain vmat2 inhibitors |
-
2020
- 2020-12-18 MX MX2022007304A patent/MX2022007304A/es unknown
- 2020-12-18 EP EP20842786.4A patent/EP4076463A1/en active Pending
- 2020-12-18 CA CA3165481A patent/CA3165481A1/en active Pending
- 2020-12-18 CN CN202080094379.0A patent/CN115003305A/zh active Pending
- 2020-12-18 BR BR112022012246A patent/BR112022012246A2/pt unknown
- 2020-12-18 US US17/757,672 patent/US20230051268A1/en active Pending
- 2020-12-18 JP JP2022537669A patent/JP2023508011A/ja active Pending
- 2020-12-18 AU AU2020408557A patent/AU2020408557A1/en active Pending
- 2020-12-18 TW TW109145085A patent/TW202137986A/zh unknown
- 2020-12-18 WO PCT/US2020/065891 patent/WO2021127359A1/en not_active Ceased
- 2020-12-18 KR KR1020227023903A patent/KR20220119065A/ko active Pending
-
2025
- 2025-08-06 JP JP2025131238A patent/JP2025160480A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2404750C2 (ru) | Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту | |
| JP6196041B2 (ja) | 大うつ病を有する患者において減量療法を提供する方法 | |
| JP6837486B2 (ja) | 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法 | |
| JP2021120379A5 (https=) | ||
| FI3518933T4 (fi) | Menetelmiä kohtumyooman ja endometrioosin hoitamiseksi | |
| RU2008150622A (ru) | Лечение агонистом мелатонина | |
| US11744808B2 (en) | Compositions and methods for treating non-alcoholic steatohepatitis | |
| JP2008509224A5 (https=) | ||
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JP4996803B2 (ja) | 抗高血圧剤に対する抵抗性及び関連状態を処置する方法及び処方物 | |
| JP2020500864A5 (https=) | ||
| RU2008102911A (ru) | Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JPWO2008090736A1 (ja) | アルツハイマー型認知症の予防及び治療のための医薬 | |
| JP2023508011A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| Bae et al. | Stevens-johnson syndrome induced by carbamazepine treatment in a patient who previously had carbamazepine induced pruritus-a case report | |
| Rabben et al. | Interindividual differences in the analgesic response to ketamine in chronic orofacial pain | |
| JP2019535830A5 (https=) | ||
| IE851848L (en) | Propiophenone compound against sexual dysfunction | |
| US20180289708A1 (en) | Low dose oral dipyridamole compositions and uses thereof | |
| RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
| McHutchison et al. | 745 Efficacy and safety of eltrombopag, an oral platelet growth factor, in subjects with HCV associated thrombocytopenia: Preliminary results from a phase II dose-ranging study | |
| JPH10506097A (ja) | Ｊｅｔ ｌａｇを緩和するための方法と医薬 | |
| JP4384435B2 (ja) | くしゃみ抑制組成物 |